Insider Buying: Bausch Health Companies Inc. (TSE:BHC) Director Purchases 502,688 Shares of Stock

Bausch Health Companies Inc. (TSE:BHC - Get Free Report) Director John Paulson purchased 502,688 shares of the business's stock in a transaction that occurred on Thursday, June 12th. The stock was bought at an average cost of C$7.44 per share, for a total transaction of C$3,739,596.57.

John Paulson also recently made the following trade(s):

• On Friday, June 13th, John Paulson bought 1,782,030 shares of Bausch Health Companies stock. The shares were bought at an average cost of C$8.14 per share, with a total value of C$14,501,803.73.
• On Wednesday, June 11th, John Paulson acquired 514,549 shares of Bausch Health Companies stock. The stock was purchased at an average price of C$7.13 per share, for a total transaction of C$3,666,881.99.
• On Tuesday, June 10th, John Paulson purchased 754,134 shares of Bausch Health Companies stock. The shares were acquired at an average price of C$6.87 per share, for a total transaction of C$5,179,392.31.

Bausch Health Companies Stock Performance

Bausch Health Companies stock traded down C$0.23 during mid-day trading on Thursday, reaching C$8.23. The company's stock had a trading volume of 127,169 shares, compared to its average volume of 359,570. The firm's fifty day moving average price is C$6.82 and its two-hundred day moving average price is C$9.04. The company has a debt-to-equity ratio of -1,831.94, a quick ratio of 0.58 and a current ratio of 1.19. Bausch Health Companies Inc. has a 12-month low of C$5.45 and a 12-month high of C$13.74. The company has a market capitalization of C$2.14 billion, a P/E ratio of -12.04, a PEG ratio of 0.21 and a beta of 0.77.

Bausch Health Companies Company Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.